Tag
MedPlus Health Services Limited
7 articles
MedPlus Board Meeting Scheduled May 29, 2026
MedPlus Health Services Board meeting scheduled on May 29, 2026 to approve audited standalone and consolidated financial results.
Results pertain to Q4 and full financial year ended March 31, 2026; fi
MedPlus Subsidiary's Store Drug License Suspended for Two Days
MedPlus Health Services disclosed a two-day drug license suspension for a Telangana store, with a potential revenue impact of Rs. 0.16 lakhs.
The suspension order was received on April 2, 2026, for a
MedPlus Subsidiary Drug License Suspended 3 Days
Optival Health Solutions, a MedPlus subsidiary, received a 3-day drug license suspension for its Parkal Main Road, Telangana store.
The suspension order was issued by the Assistant Director, Drugs Con
MedPlus Subsidiary Drug License Suspended, Karnataka
Optival Health Solutions Pvt Ltd, MedPlus subsidiary, received a 3-day drug license suspension for its Dharwad, Karnataka store.
The suspension was ordered by Assistant Director, Drugs Control Adminis
MedPlus Postal Ballot: RPT with Optival Approved
MedPlus Health Services Limited shareholders approved material related party transactions with Optival Health Solutions Private Limited, its material subsidiary, via postal ballot.
The ordinary resolu
MedPlus Reg 30 Disclosure Delay Clarification
MedPlus Health Services filed a clarification to BSE and NSE regarding delay in Regulation 30 disclosure under SEBI (LODR) Regulations, 2015.
The delay was attributed to inadvertent oversight; the mat
MedPlus Subsidiary Drug License Suspended in Karnataka
Optival Health Solutions, a MedPlus subsidiary, received a 3-day drug license suspension for its Mandya, Karnataka store.
The suspension was issued by the Assistant Director, Drugs Control Administrat